Japan drug approvals

top of page

iPharmaCenter

Global | Comprehensive | Patient Centric

Home
News
Regional News
Diseases
Disease News
Healthcare Policies
Conferences
COVID-19
Contact
More

Use tab to navigate through the menu items.

All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam

Search

Drug approvals in Japan | PMDA | MHLW Approvals | 2022 | 2023 | News | Media | Japan | iPharmaCenter

ipharmaservices

Dec 24, 2022

Drug approvals in Japan | PMDA | MHLW Approvals | 2022 | 2023 | News | Media | Japan | iPharmaCenter

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

ipharmaservices

Jan 12, 2021

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

ipharmaservices

Sep 26, 2020

Gilead received the approval of Jyseleca from the European and Japan regulatory authorities for RA

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

ipharmaservices

Aug 22, 2020

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

JAPAN HEALTHCARE SYSTEM

ipharmaservices

Aug 17, 2020

JAPAN HEALTHCARE SYSTEM

ipharmaservices

Jul 9, 2020

Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia

AstraZeneca's Lokelma approved in Japan

ipharmaservices

Mar 29, 2020

AstraZeneca's Lokelma approved in Japan

For sponsored articles and advertisements, please write to ipharmaservices@gmail.com

Healthcare Policies

©2022 by ipharmaservices

iPharmaCenter

bottom of page